Atherectomy Device Market by Product (Directional Atherectomy Systems, Orbital Atherectomy Systems, Photo-Ablative Atherectomy Systems, and Rotational Atherectomy Systems), Application (Peripheral Vascular Applications, Cardiovascular Applications and Neurovascular Applications), and End User (Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2029

Atherectomy is a minimally invasive endovascular surgery for removal of atherosclerotic plaque from affected arteries. Atherectomy devices help and assist the atherectomyprocedure for cleaning the clogged arteries majorly calcium deposits. These devices are of four types namely; rotational, orbital, directional, and laser. Atherectomy involves using a catheterwith a sharp blade for cutting, sanding, shaving, or vaporizing atherosclerotic plaque from the arteries. This procedure is mainly used in treating peripheral and coronaryarterial disease as an alternative to angioplasty. This procedure has advantages over conventional procedures as it treats complex lesions, less dissection,and acute occlusion and reduces restenosis rate in humans. 

As per the data published by CDC, in 2016, the population suffering from peripheral artery disease (PAD) alone is approximately 8.5 million,including 12-20% of individuals older than age 60 in the U.S. alone. Moreover, in 2017, CDC published coronary heart disease (CHD) is the most common heart diseasekilling approximately 370,000 people in the U.S.every year.  Thus, this is expected to provide lucrative opportunities for the growth of theatherectomy device market. 

The factors such as rise inpreference for minimally invasive surgeries and increase inprevalence of peripheral & coronary heart diseases are expectedto boost the growth of the atherectomy device market in thecoming years. Furthermore, favorable medical reimbursement scenario from the government is anticipated to propel theatherectomy devicemarket growth. However, lack of skilled professionals and stringent regulatory scenario is expected to restrain the market growth.

The atherectomy device market is segmented on the basis ofproduct, application, end user, and region. Based on product, the market is categorized into directional atherectomy systems, orbital atherectomy systems, photo-ablative atherectomy systems, and rotational atherectomy systems. By application, itis classified into peripheral vascular applications, cardiovascular applications, and neurovascular applications. Based on end user, the market is divided into hospitals & surgical centers, ambulatory care centers, research laboratories & academic institutes, and others. Based on region, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA. 

Major players operating in the atherectomy device market include Boston Scientific Corporation, Cardiovascular Systems, Inc., Avinger, Inc., Spectranetics Corporation (Philips Holding USA Inc.), Medtronic plc, St. Jude Medical, Inc. (Abbott Laboratories), Straub Medical AG, Bard Peripheral Vascular, Inc., Volcano Corporation, and Terumo Corporation. Some of the other players operating in the market are Cardinal Health (Cordis) and Biomerics, LLC.The prominent players in the market have adopted various strategies for increasing their atherectomy device market share. For instance, recently, in 2019, Rex Medical received FDA clearance for its revolution peripheral atherectomy system. In addition, Cardiovascular Systems, Inc. received FDA approval of the Coronary ViperWire Advance with Flex Tip. It is the latest advancement for CSI’s coronary Diamondback 360 that is used to treat calcific coronary artery disease. 

Key Benefits For Stakeholders

• This report provides a detailed quantitative analysis of the current atherectomy device market trends and forecast estimations from 2019 to 2027, which assists to identify the prevailing market opportunities. 

• An in-depth atherectomy device market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

• A comprehensive analysis of the factors that drive and restrain the growth of the global atherectomy device market is provided.

• Region-wise and country-wise atherectomy device Market conditions are comprehensively analyzed in this report.

• The projections in this report are made by analyzing the current atherectomy device market trends and fu-ture market potential from 2019 to 2027 in terms of value.

• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

• The key players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global market.  

Key Market Segments

By Product

• Directional Atherectomy Systems
• Orbital Atherectomy Systems
• Photo-Ablative (Laser) Atherectomy Systems
• Rotational Atherectomy Systems

By Application

• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

By End User

• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

 Key Market Segments

 Key Market Players

• Boston Scientific Corporation
• Cardiovascular Systems Inc.
• Avinger Inc.
• Spectranetics Corporation (Philips Holding USA Inc.)
• Medtronic plc
• St. Jude Medical Inc. (Abbott Laboratories)
• Straub Medical AG
• Bard Peripheral Vascular Inc.
• Volcano Corporation
• Terumo Corporation
• Cardinal Health (Cordis)